ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026
Targeted KEAP1 disruption enhances antioxidant defense and mesenchymal stromal cell therapy for chronic limb-threatening ischemia.
Eun Ji Shin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.